Pfizer buys herpes vaccine company
This article was originally published in Scrip
Executive Summary
Pfizer has continued its recent deal-making spree with the acquisition of a "controlling interest" in Redvax, a spin-off from Redbiotec, a privately held Swiss biopharmaceutical company.